Fig. 1.

Study overview – assessment of differences in HBV-HCC tumor recurrence in patients of low and high liver fibrosis stage. Twenty-one pairs of non-neoplastic liver and HBV-HCC tumor samples of varying liver fibrosis status were collected from surgical resection and their transcriptome was profiled through RNAseq technique. Their clinical and genomic features were compared through comprehensive analysis based on liver fibrosis stage and tumor recurrence status